Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
ReposiTrak | TRAK | 5. nov 2024 | 19.50 | +2.79 |
Republic Bancorp A | RBCAA | 5. nov 2024 | 68.12 | +3.17 |
Republic Services | RSG | 5. nov 2024 | 202.14 | +0.77 |
Research Frontiers | REFR | 5. nov 2024 | 2.15 | +0.47 |
Research Solutions | RSSS | 5. nov 2024 | 2.56 | -1.54 |
Reservoir Media | RSVR | 5. nov 2024 | 8.49 | +1.92 |
ReShape Lifesciences | RSLS | 5. nov 2024 | 6.02 | -0.50 |
Resideo Technologies | REZI | 5. nov 2024 | 20.54 | +2.29 |
ResMed | RMD | 5. nov 2024 | 245.74 | +0.87 |
Resources Connection | RGP | 5. nov 2024 | 8.13 | +1.75 |
Restaurant Brands International | QSR | 5. nov 2024 | 68.20 | -2.63 |
Retail Bull 3X Direxion | RETL | 5. nov 2024 | 9.13 | +4.10 |
Retail ETF Market Vectors | RTH | 5. nov 2024 | 220.31 | +0.98 |
Retail Opportunity Investments | ROIC | 5. nov 2024 | 16.59 | -1.25 |
ReTo Eco-Solutions | RETO | 5. nov 2024 | 1.10 | -0.90 |
Retractable Technologies | RVP | 5. nov 2024 | 0.72 | +0.22 |
REV Group | REVG | 5. nov 2024 | 27.85 | +3.03 |
Revance Therapeutics | RVNC | 5. nov 2024 | 5.84 | +0.52 |
Revelation Biosciences | REVB | 5. nov 2024 | 0.88 | +3.35 |
Revenueshares Largecap | RWL | 5. nov 2024 | 98.16 | +0.95 |
Revenueshares Midcap | RWK | 5. nov 2024 | 117.18 | +1.37 |
Revenueshares Smallcap | RWJ | 5. nov 2024 | 45.56 | +2.15 |
Revenueshares Ultra Dividend Fund | RDIV | 5. nov 2024 | 49.95 | +1.03 |
Reviva Pharmaceuticals | RVPH | 5. nov 2024 | 0.92 | -8.29 |
Revolution Medicines | RVMD | 5. nov 2024 | 56.75 | +1.58 |
Revolve Group A | RVLV | 5. nov 2024 | 26.02 | +2.97 |
Revvity | RVTY | 5. nov 2024 | 125.96 | +0.91 |
REX American Resources | REX | 5. nov 2024 | 46.28 | +1.36 |
Rexford Industrial Realty | REXR | 5. nov 2024 | 43.74 | +1.32 |
Rexford Industrial Realty B Pref | REXR-B | 5. nov 2024 | 23.20 | +0.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.